BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3297 related articles for article (PubMed ID: 7544613)

  • 1. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
    Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
    Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.
    Mayorov AV; Cai M; Palmer ES; Liu Z; Cain JP; Vagner J; Trivedi D; Hruby VJ
    Peptides; 2010 Oct; 31(10):1894-905. PubMed ID: 20688117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.
    Loser K; Brzoska T; Oji V; Auriemma M; Voskort M; Kupas V; Klenner L; Mensing C; Hauschild A; Beissert S; Luger TA
    PLoS One; 2010 Feb; 5(2):e8958. PubMed ID: 20126537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.
    Mayorov AV; Han SY; Cai M; Hammer MR; Trivedi D; Hruby VJ
    Chem Biol Drug Des; 2006 May; 67(5):329-35. PubMed ID: 16784457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants.
    Botha R; Kumar SS; Grimsey NL; Mountjoy KG
    J Mol Endocrinol; 2023 Jul; 71(1):. PubMed ID: 37040537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding and biological activity of IL-1 alpha, IL-1 beta, IL-1 beta analogues and an IL-1 antagonist in A375 human melanoma cells.
    Baumann JB; Christen E; Gamboni G; Joss U; van Oostrum J; Girard J; Eberle AN
    J Recept Res; 1993; 13(1-4):245-62. PubMed ID: 8450493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: Duncan LM, Bouffard D, Howard C, Mihm MC Jr, Byers HR: In situ distribution of integrin alpha 2 beta 1 and alpha-actinin in melanocytic proliferation. Mod Pathol 9:938, 1996.
    Cramer SF
    Mod Pathol; 1996 Dec; 9(12):1178-9. PubMed ID: 8972479
    [No Abstract]   [Full Text] [Related]  

  • 8. Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines.
    Perlaky L; Busch RK; Busch H
    Oncol Res; 1996; 8(9):363-9. PubMed ID: 8979270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
    Hoon DS; Hayashi Y; Morisaki T; Foshag LJ; Morton DL
    Cancer Immunol Immunother; 1993 Nov; 37(6):378-84. PubMed ID: 8242663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin interactions with cultured murine B16 melanoma cells.
    Helton RA; Harrison WA; Kelley K; Kane MA
    Melanoma Res; 1993 Dec; 3(6):403-13. PubMed ID: 8161880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence.
    Zölzer F; Streffer C; Pelzer T
    Int J Radiat Biol; 1993 Jan; 63(1):69-76. PubMed ID: 8093469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate interleukin-4.
    Krauss JC; Strome SE; Chang AE; Shu S
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):77-84. PubMed ID: 7804530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin cancers and environmental factors].
    Autier P
    Rev Med Brux; 1998 Sep; 19(4):A346-50. PubMed ID: 9805971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer approaches to regional cancer therapy through tumour immunology: is there a 'breakthrough'?
    Stephens FO
    Aust N Z J Surg; 1997 Jan; 67(1):2-4. PubMed ID: 9033367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymph node dissections in malignant melanoma].
    Hohenberger W; Göhl J; Altendorf-Hofmann A; Meyer T
    Chirurg; 1996 Aug; 67(8):779-87. PubMed ID: 8964150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dislocated intraocular lens simulating a choroidal melanoma.
    Abramson DH; Servodidio CA
    Insight; 1995 Oct; 20(3):18-9. PubMed ID: 7594913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI diagnosis of intramedullary metastases from extra-CNS tumors.
    Crasto S; Duca S; Davini O; Rizzo L; Pavanello IG; Avataneo T; Cirillo S; Regge D; Soffietti R
    Eur Radiol; 1997; 7(5):732-6. PubMed ID: 9166574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice.
    Huang TS; Rauth S; Das Gupta TK
    Anticancer Res; 1996; 16(6B):3557-63. PubMed ID: 9042221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgically treated malignant melanoma. The long-term results].
    Meierovici D; Ceauşu M; Păun F
    Chirurgia (Bucur); 1995; 44(4):69-71. PubMed ID: 8646029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in survival rate of patients with acral melanoma observed in the past 22 years in Sendai, Japan.
    Kato T; Suetake T; Sugiyama Y; Tanita Y; Kumasaka K; Takematsu H; Tomita Y; Tagami H
    Clin Exp Dermatol; 1993 Mar; 18(2):107-10. PubMed ID: 8481983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 165.